Niagen Bioscience, Inc. SEC filings NAGE
Niagen Bioscience, Inc. has 981 filings in SEC EDGAR's recent list, going back to Jan 18, 2007. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 4, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Oct 31, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 8, 2024 | Mar 31, 2024 |
| 10-Q | Quarterly report | Nov 8, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 10, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 2, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 3, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 3, 2021 | Jun 30, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 10-Q | Quarterly report | Nov 4, 2020 | Sep 30, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 10-Q | Quarterly report | May 18, 2020 | Mar 31, 2020 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 7, 2019 | Jun 30, 2019 |
| 10-Q | Quarterly report | May 9, 2019 | Mar 31, 2019 |
| 10-Q | Quarterly report | Nov 7, 2018 | Sep 30, 2018 |
| 10-Q | Quarterly report | Aug 9, 2018 | Jun 30, 2018 |
| 10-Q | Quarterly report | May 10, 2018 | Mar 31, 2018 |
| 10-Q | Quarterly report | Nov 9, 2017 | Sep 30, 2017 |
| 10-Q | Quarterly report | Aug 10, 2017 | Jul 1, 2017 |
| 10-Q | Quarterly report | May 11, 2017 | Apr 1, 2017 |
| 10-Q | Quarterly report | Nov 10, 2016 | Oct 1, 2016 |
| 10-Q/A | Amended quarterly report | Aug 26, 2016 | Apr 2, 2016 |
| 10-Q | Quarterly report | Aug 11, 2016 | Jul 2, 2016 |
| 10-Q | Quarterly report | May 12, 2016 | Apr 2, 2016 |
| 10-Q | Quarterly report | Nov 12, 2015 | Oct 3, 2015 |
| 10-Q | Quarterly report | Aug 13, 2015 | Jul 4, 2015 |
| 10-Q | Quarterly report | May 14, 2015 | Apr 4, 2015 |
| 10-Q | Quarterly report | Nov 6, 2014 | Sep 27, 2014 |
| 10-Q | Quarterly report | Aug 12, 2014 | Jun 28, 2014 |
| 10-Q | Quarterly report | May 8, 2014 | Mar 29, 2014 |
| 10-Q/A | Amended quarterly report | Dec 5, 2013 | Jun 29, 2013 |
| 10-Q/A | Amended quarterly report | Dec 5, 2013 | Mar 30, 2013 |
| 10-Q | Quarterly report | Nov 21, 2013 | Sep 28, 2013 |
| 10-Q | Quarterly report | Aug 13, 2013 | Jun 29, 2013 |
| 10-Q | Quarterly report | May 10, 2013 | Mar 30, 2013 |
| 10-Q | Quarterly report | Nov 8, 2012 | Sep 29, 2012 |
| 10-Q/A | Amended quarterly report | Aug 10, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | Aug 9, 2012 | Jun 30, 2012 |
| 10-Q | Quarterly report | May 10, 2012 | Mar 31, 2012 |
| 10-Q | Quarterly report | Nov 10, 2011 | Sep 30, 2011 |
| 10-Q/A | Amended quarterly report | Oct 12, 2011 | Jul 2, 2011 |
| 10-Q | Quarterly report | Aug 11, 2011 | Jul 2, 2011 |
| 10-Q | Quarterly report | May 12, 2011 | Apr 2, 2011 |
| 10-Q | Quarterly report | Nov 16, 2010 | Oct 2, 2010 |
| 10-Q | Quarterly report | Aug 17, 2010 | Jul 3, 2010 |
| 10-Q | Quarterly report | May 18, 2010 | Apr 3, 2010 |
| 10-Q | Quarterly report | Nov 17, 2009 | Oct 3, 2009 |
| 10-Q | Quarterly report | Aug 18, 2009 | Jul 4, 2009 |
| 10-Q | Quarterly report | May 15, 2009 | Apr 4, 2009 |
| 10-Q | Quarterly report | Nov 12, 2008 | Sep 27, 2008 |
| 10-Q | Quarterly report | Aug 12, 2008 | Jun 28, 2008 |
Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NAGE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Los Angeles, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1386570
- Former names
- ChromaDex Corp. (until Mar 10, 2025); CODY RESOURCES, INC. (until Jun 24, 2008)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.